News
Keytruda made available on the NHS for certain oesophageal cancer patients
The National Institute for Health and Care Excellence (NICE) has recommended MSD’s Keytruda (pembrolizumab) combined with chemotherapy for the first-line treatment of certain oesophageal cancer patients.